Safety and Efficacy Study of RA101495 in Subjects With Generalized Myasthenia Gravis
Clinical trial NCT03315130 · COMPLETED
Trial details
- NCT number
- NCT03315130
- Sponsor
- Ra Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-11
- Primary completion
- 2018-12-10
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.